XML 36 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMITMENTS AND CONTINGENT LIABILITIES (Details)
 3 Months Ended 6 Months Ended 12 Months Ended 129 Months Ended 0 Months Ended 12 Months Ended 12 Months Ended
Jun. 30, 2012
USD ($)
sqft
Jun. 30, 2011
USD ($)
Jun. 30, 2012
USD ($)
sqft
Jun. 30, 2011
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2010
USD ($)
Dec. 31, 2009
USD ($)
Dec. 31, 2004
USD ($)
Dec. 31, 2004
ILS
Jun. 30, 2012
USD ($)
sqft
Jun. 30, 2012
ILS
Jul. 29, 2011
Placement Agent [Member]
USD ($)
May 31, 2011
Placement Agent [Member]
USD ($)
Apr. 29, 2011
Placement Agent [Member]
USD ($)
Mar. 31, 2011
Placement Agent [Member]
USD ($)
Jan. 31, 2011
Placement Agent [Member]
USD ($)
Dec. 30, 2010
Placement Agent [Member]
USD ($)
Dec. 16, 2010
Placement Agent [Member]
USD ($)
Dec. 31, 2011
Placement Agent [Member]
perUnitItemType
Dec. 31, 2010
Placement Agent [Member]
perUnitItemType
Dec. 31, 2011
Agreement with Placement Agent [Member]
USD ($)
Dec. 31, 2010
Agreement with Placement Agent [Member]
USD ($)
Dec. 31, 2010
December Offering [Member]
Minimum [Member]
USD ($)
Dec. 31, 2010
December Offering [Member]
Maximum [Member]
USD ($)
Dec. 31, 2004
Payment of Royalties to OCS [Member]
USD ($)
Jun. 30, 2012
Payment of Royalties to OCS [Member]
USD ($)
Jun. 30, 2012
Arbitration Proceedings with Shareholder [Member]
Commitments and Legal Proceedings:                                                      
Research and development grants                      $ 93,462 420,000 $ 93,462                             $ 93,462    
Percent of budget funded by grant                                                 60.00%    
Maximum royalties payable                                                 93,462    
Royalty on the sale of any product developed within first 3 years                                                 3.00%    
Royalty on the sale of any product developed within years 4, 5, and 6                                                 4.00%    
Royalty on the sale of any product developed after 6th year                                                 5.00%    
Contingent liabilities with respect to the grants                                                   93,462  
Ownership and anti-dilution percentage at issue                                                     18.00%
Lease Disclosures:                                                      
Office space leased 3,100   3,100             3,100                                  
Monthly lease payment 2,931   2,931             2,931 11,500                                
The Offering:                                                      
Number of shares to be issued in offering                                             560,000 2,000,000      
Value of shares to be issued in offering                                             3,500,000 12,500,000      
Commission fee percentage                                           7.00%          
Management fee percentage                                           3.00%          
Non-accountable expense allowance percentage                                           3.00%          
Total percent of funding to be paid to agent                                           13.00%          
Percent of shares issued covered by warrants                                           10.00%          
Payments made to agent                       $ 219,115 $ 27,788 $ 32,500 $ 73,749 $ 13,260 $ 39,000 $ 392,112     $ 366,412 $ 753,850          
Warrants Issued:                                                      
Number of warrants issued                       26,968 3,420 4,000 9,077 1,632 4,800 48,260 45,097 83,281              
Warrant exercise price                                     6.25 6.25